In this study, we first used The Cancer Genome Atlas (TCGA) data to conduct a pan-cancer analysis on NOLC1 expression and found that NOLC1 expression was elevated in colorectal cancer, esophageal cancer, bile duct cancer, and other tumor tissues. Here, NOLC1 is linked to bile duct cancer.